Mesalamine-induced Myocarditis
Overview
Authors
Affiliations
Nowadays mesalamine is a common treatment for Crohn's disease and hypersensitive reactions to this product have been reported. Yet there is limited information concerning mesalamine-induced myocarditis and its mechanism is not known. We described a case of mesalamine-induced myocarditis in Crohn's disease of the colon.
Cardiac magnetic resonance in a rare case of recurrent mesalazine-induced myocarditis.
Dicorato M, Caretto P, Colucci C, Ciaccia M, Rella M, Muscogiuri E Future Cardiol. 2024; 20(4):183-189.
PMID: 38963120 PMC: 11285267. DOI: 10.1080/14796678.2024.2373558.
Myocarditis Related to the Use of Mesalazine.
Kyriakou M, Sakellaropoulos S, Constantinides T, Chatzantonis G, Avraamides P, Mitsis A J Med Cases. 2023; 14(7):237-243.
PMID: 37560552 PMC: 10409542. DOI: 10.14740/jmc4104.
Analysis of clinical characteristics of mesalazine-induced cardiotoxicity.
Chen J, Duan T, Fang W, Liu S, Wang C Front Pharmacol. 2022; 13:970597.
PMID: 36188558 PMC: 9520406. DOI: 10.3389/fphar.2022.970597.
Caio G, Lungaro L, Caputo F, Muccinelli M, Marcello M, Zoli E BMJ Open Gastroenterol. 2021; 8(1).
PMID: 33722804 PMC: 7970288. DOI: 10.1136/bmjgast-2020-000587.
Mesalamine-Induced Myopericarditis: A Case Report and Literature Review.
Taha M, Abdalla A, Al-Khafaji J, Malik S Cardiol Res. 2019; 10(1):59-62.
PMID: 30834061 PMC: 6396800. DOI: 10.14740/cr820.